to IndUS Pharmaceuticals, Inc.
IndUS Pharmaceuticals, Inc. is a cross-border pharmaceutical enterprise which is focused on the discovery and development of novel small molecule drugs for the treatment of cancer, diabetes and infectious diseases. The Company has an experienced management team with several years of experience in small molecule drug discovery and development. In addition, the Company has retained advisors from major academic centers in the US and India. IndUS Pharmaceuticals is headquartered in the Greater Boston area.
IndUS leverages India’s natural product chemistry expertise and strengths in traditional and ancient plant-based medicines (e.g. Siddha), for discovery of novel drugs for treatment of cancer, diabetes and various infectious diseases. The therapeutic areas chosen by IndUS have a rich history of successes from natural product-based research and approximately 80% of the marketed drugs in cancer, diabetes and infectious diseases are either derived from or based on natural products.
The Company’s research and development (R&D) platform leverages a cross-border model by leveraging the geographic niches of India (in chemistry, natural product research and ancient traditional Indian medicine) and the United States (in biology, drug discovery, and clinical biomarker and drug development). IndUS also leverages in-licensing opportunities from the intellectual property on novel technologies from institutes of excellences, such as those affiliated with the Council of Scientific and Industrial Research (CSIR) and other academic institutions. The Company’s unique, cross-border, knowledge-transfer business model has allowed the Company to rapidly establish key technology platforms for the discovery and development of novel and innovative drugs through its network and operations in the United States and India.